RESUMEN
STUDY OBJECTIVE: To compare sevoflurane induction times and complications in children during a high concentration, primed-circuit method and an incremental induction technique. DESIGN: Randomized, prospective open-label study. SETTING: Academic university hospital. PATIENTS: 40 unpremedicated ASA physical status I and II children age 4 months to 15 years undergoing elective surgical procedures with general anesthesia. INTERVENTIONS: Patients were randomized to one of two study groups. In the high concentration group, the anesthesia circuit was primed with 8% sevoflurane in a 2:1 nitrous oxide:oxygen (N2O:O2) mixture. Patients breathed this gas mixture spontaneously until loss of the eyelash reflex. In the incremental group, the face mask was applied and 1% sevoflurane in a 2:1 N2O:O2 mixture was administered. In this group, the sevoflurane concentration was increased by 1% every 2 to 3 breaths. Gas flows of 6 L/min were administered to both groups during the study period. Following loss of the eyelash reflex, the sevoflurane concentration was decreased to 5% until a depth of anesthesia sufficient to start an intravenous catheter was achieved. MEASUREMENTS AND MAIN RESULTS: Induction cooperation, induction time (face mask application to loss of the eyelash reflex), one-minute vital signs [blood pressure, heart rate, oxygen saturation via pulse oximetry (SpO2)], induction complications. Induction of anesthesia was faster in the high concentration group than in the incremental group (mean (SD) 42 (9) sec vs. 66 (12) sec, respectively; p < 0.001). Induction complications were minor and occurred with similar frequencies (4/20 patients vs. 3/20 patients). There were no significant intergroup heart rate, blood pressure, or SpO2 differences during induction. No patients required treatment for hypotension or bradycardia. CONCLUSIONS: In healthy pediatric patients undergoing mask induction of general anesthesia with sevoflurane, the induction time can be significantly shortened without an increase in the frequency of airway or vital sign complications using a high concentration, primed circuit technique compared with a conventional, incremental induction method.
Asunto(s)
Anestesia por Inhalación , Anestésicos por Inhalación , Anestésicos por Inhalación/administración & dosificación , Éteres Metílicos , Éteres Metílicos/administración & dosificación , Capacidad Vital/fisiología , Adolescente , Anestesia por Inhalación/efectos adversos , Anestésicos por Inhalación/efectos adversos , Niño , Preescolar , Método Doble Ciego , Femenino , Hemodinámica/fisiología , Humanos , Lactante , Complicaciones Intraoperatorias , Masculino , Éteres Metílicos/efectos adversos , Sevoflurano , Factores de TiempoRESUMEN
Oral transmucosal fentanyl citrate (OTFC) is a labeled preoperative pediatric sedative. Doses greater than 15 micrograms/kg are associated with a high incidence of post-operative nausea and vomiting and occasional respiratory depression. We studied the safety and efficacy of OTFC in children 6 yr old and younger at a dose of 15 micrograms/kg. Nineteen patients undergoing surgery associated with postoperative pain were randomized to receive OTFC/intravenous (IV) saline or placebo lozenge/IV fentanyl. After 45 min, patients receiving OTFC became more sedated than the placebo group, but there were no differences in cooperation, apprehension, parental separation, or induction cooperation scores. Preoperatively, neither respiratory depression nor oxygen desaturation occurred. Nine of 10 OTFC patients developed mild pruritus, and three of 10 OTFC patients vomited preoperatively; neither complication occurred in the placebo group. (The high incidence of preoperative vomiting led to the termination of the protocol before the anticipated enrollment of 40 patients.) General anesthesia was induced via a mask, followed by a propofol infusion. Spo2 and respiratory rate were monitored, and sedation, apprehension, cooperation, ease of parental separation, and induction cooperation were scored. One OTFC patient developed rigidity during induction. Emergence and recovery were not delayed by OTFC despite a 50% incidence of postoperative vomiting. We do not recommend the use of OTFC in a 15 micrograms/kg dose as a routine preoperative sedative in children 6 yr old and younger.
Asunto(s)
Analgésicos Opioides/administración & dosificación , Fentanilo/administración & dosificación , Hipnóticos y Sedantes/administración & dosificación , Administración Oral , Analgésicos Opioides/efectos adversos , Periodo de Recuperación de la Anestesia , Ansiedad/etiología , Ansiedad de Separación/etiología , Niño , Conducta Infantil/efectos de los fármacos , Preescolar , Conducta Cooperativa , Fentanilo/efectos adversos , Humanos , Hipnóticos y Sedantes/efectos adversos , Inyecciones Intravenosas , Náusea/inducido químicamente , Oxígeno/sangre , Dolor Postoperatorio/prevención & control , Placebos , Complicaciones Posoperatorias , Medicación Preanestésica , Premedicación , Prurito/inducido químicamente , Respiración/efectos de los fármacos , Seguridad , Vómitos/inducido químicamente , Vigilia/efectos de los fármacosRESUMEN
STUDY OBJECTIVE: To compare vital signs and the speed of induction and emergence with sevoflurane versus halothane in pediatric patients. DESIGN: Prospective, randomized, open study. SETTING: Thomas Jefferson University Hospital. PATIENTS: 40 unpremedicated ASA Physical Status I and II children age 9 months to 16 years undergoing elective inpatient otorhinolaryngologic or orthopedic surgery. INTERVENTIONS: Standardized induction of anesthesia with sevoflurane (start: 1%, maximum: 7%) or halothane (start: 0.5%, maximum: 5%) in nitrous oxide/oxygen (N2O/O2). Intubation following vecuronium and 4 minutes of controlled ventilation with 2 minimum alveolar concentration (MAC) drug in O2; 1.5 MAC drug in N2O/O2 delivered for 20 minutes; then 0.75 MAC until the end of surgery. Fentanyl 1 mcg/kg was administered 15 minutes before the anticipated end of surgery, at which time anesthetics were stopped and mechanical ventilation continued until eye opening (emergence). MEASUREMENTS AND MAIN RESULTS: Blood pressure, heart rate (HR), oxygen saturation, end-tidal gas concentrations, and temperature were recorded. Induction and emergence times were measured to the nearest second. Induction (loss of eyelash reflex) was faster with sevoflurane (97 +/- 31 sec) than halothane (120 +/- 36 sec; p < 0.05), despite a lower inspired sevoflurane MAC. Emergence was faster with sevoflurane (9.9 +/- 2.9 min vs. 12.5 +/- 4.7 min; p < 0.05), despite a higher MAC multiple of end-tidal sevoflurane concentration at the end of surgery. Following intubation, HR (compared with the preinduction value in the operating room) was significantly higher in the halothane group (136.8% +/- 16.3% vs. 115.0% +/- 25.6%), as was mean arterial pressure (113.2% +/- 25.5% vs. 87.8% +/- 22.6%). This finding corresponded with a higher MAC multiple of end-tidal concentration in the sevoflurane group than in the halothane group. CONCLUSIONS: Induction of and emergence from anesthesia was faster with sevoflurane than halothane. Airway complications were low in both groups. Vital signs were more stable with sevoflurane during induction through intubation, and were comparable during maintenance. Sevoflurane is an excellent drug for inhalational induction in pediatric patients.
Asunto(s)
Anestesia General , Éteres/farmacología , Halotano/farmacología , Hemodinámica/efectos de los fármacos , Éteres Metílicos , Adolescente , Anestesia General/efectos adversos , Niño , Preescolar , Éteres/efectos adversos , Estudios de Evaluación como Asunto , Halotano/efectos adversos , Humanos , Lactante , Estudios Prospectivos , Sevoflurano , Factores de TiempoRESUMEN
STUDY OBJECTIVE: To compare desflurane with isoflurane in several anesthetic situations. DESIGN: Intubating conditions, hemodynamic response to intubation, maintenance hemodynamics, and speed of recovery from desflurane and isoflurane anesthesia were evaluated. In addition, interaction with a muscle relaxant at low and high concentrations of the anesthetics were compared. SETTING: Thomas Jefferson University Hospital. PATIENTS: Thirty-two patients who received general anesthesia for lengthy, mostly orthopedic procedures. INTERVENTIONS: Immediately after induction with thiopental sodium, desflurane or isoflurane in nitrous oxide-oxygen was administered via face mask. Anesthesia was deepened until end-tidal concentration reached 1.7 minimum alveolar concentration (MAC). The trachea was intubated without the aid of a muscle relaxant. Heart rate (HR) and blood pressure (BP) were recorded before and at 1, 2, 4, 5, and 10 minutes after intubation. Noninvasive cardiac output (CO) and systemic vascular resistance (SVR) were determined while the patient was awake, immediately before intubation, and at 5 and 10 minutes after intubation. Following intubation, the concentration of desflurane or isoflurane was lowered until the end-tidal concentration reached 0.65 MAC (low-MAC group), 1.25 MAC (high-MAC group), or 0 MAC (control group). Pancuronium bromide in 0.005 mg/kg doses was administered incrementally until T1 (first twitch of train-of-four) was depressed more than 90%. ED50 and ED95 for pancuronium with balanced anesthesia and for desflurane or isoflurane in low and high MACs, as well as speed of recovery, were determined. The time to responsiveness and awakening also was determined. MEASUREMENTS AND MAIN RESULTS: There was no significant difference between desflurane and isoflurane in intubating conditions or in BP or HR response to tracheal intubation. Both anesthetics increased HR significantly during induction. BP rose with desflurane at the preintubation point; other points showed no difference. A hyperdynamic response of increased HR and BP above 20% of baseline values was seen more frequently with desflurane (n = 7) than with isoflurane (n = 1). CO was elevated at all times after induction for low and high concentrations of both drugs, while SVR decreased over the same time with no significant difference between drugs. ED50 and ED95 for pancuronium were similar under desflurane and isoflurane at both low and high MAC, but they were significantly lower than under balanced anesthesia. Awakening times were similar for desflurane and isoflurane. CONCLUSIONS: Desflurane is similar to isoflurane in providing anesthesia for intubation and maintenance. Desflurane tends to increase HR and occasionally causes a hyperdynamic response during rapid deepening of anesthesia. It is very similar to isoflurane in its interaction with pancuronium.
Asunto(s)
Anestesia por Inhalación , Anestésicos , Isoflurano , Isoflurano/análogos & derivados , Adulto , Periodo de Recuperación de la Anestesia , Anestésicos/administración & dosificación , Anestésicos/farmacología , Presión Sanguínea/efectos de los fármacos , Gasto Cardíaco/efectos de los fármacos , Desflurano , Interacciones Farmacológicas , Femenino , Frecuencia Cardíaca/efectos de los fármacos , Humanos , Intubación Intratraqueal , Isoflurano/administración & dosificación , Isoflurano/farmacología , Masculino , Persona de Mediana Edad , Unión Neuromuscular/efectos de los fármacos , Pancuronio/farmacología , Intercambio Gaseoso Pulmonar , Volumen de Ventilación Pulmonar , Factores de Tiempo , Resistencia Vascular/efectos de los fármacosRESUMEN
The hemodynamic and intrapulmonary shunt effects of intravenous labetalol and nitroprusside were compared during induced hypotension for major spinal surgery. A randomized, double-blind protocol was used in which 20 patients, ASA physical status I or II, received either nitroprusside infusion (n = 10) or labetalol bolus injections of 10 mg every 10 min (n = 10) until mean arterial blood pressure was reduced to 55-60 mm Hg. Pulmonary artery pressures were measured and mixed venous samples obtained via a pulmonary artery catheter. Nitroprusside increased heart rate significantly more than labetalol during the period of hypotension. When compared with prehypotension baseline values, nitroprusside increased heart rate significantly with a concomitant significant decrease in systemic vascular resistance. Cardiac output increased significantly 60 min after hypotension was achieved in patients treated with nitroprusside. Systemic vascular resistance decreased significantly below baseline levels in patients treated with labetalol but without changes in cardiac output, heart rate, or mean pulmonary artery pressure. There was a 122% increase in intrapulmonary shunt with nitroprusside administration, compared with an 11% increase with labetalol. Labetalol was effective for inducing hypotension and was not associated with an increase in heart rate, intrapulmonary shunt, or cardiac output as seen with nitroprusside.
Asunto(s)
Ferricianuros/farmacología , Hemodinámica/efectos de los fármacos , Hipotensión Controlada/métodos , Labetalol/farmacología , Nitroprusiato/farmacología , Adulto , Anestesia General , Método Doble Ciego , Evaluación de Medicamentos , Femenino , Humanos , Isoflurano , Labetalol/administración & dosificación , Masculino , Persona de Mediana Edad , Nitroprusiato/administración & dosificación , Distribución Aleatoria , Enfermedades de la Columna Vertebral/cirugíaRESUMEN
Hypertension after carotid endarterectomy has a variable incidence ranging up to 56%. Blood pressure (BP) control is essential due to possible increased risk of morbidity from neurologic deficits or cardiovascular complications. This study evaluated intravenous labetalol for control of hypertension after carotid endarterectomy. Sixty ASA II-IV patients were studied; 20 developed BP high enough for treatment with labetalol. The anesthetic technique was standardized. Labetalol was administered at the conclusion of surgery as a 20-mg bolus over two minutes followed by 40 mg every 10 minutes until the desired BP was achieved (BP less than or equal to 10% above average preoperative BP or less than 150 mmHg, systolic) or 300 mg had been given. The mean total dose of labetalol was 42.0 +/- 33.0 mg (mean +/- SD) and mean time to reach the desired BP was 16.2 +/- 21.4 minutes. Systolic, diastolic, mean arterial pressure and heart rate significantly decreased after labetalol treatment and remained so for the remainder of the 180-minute study period. There was no hypotension, bradycardia, evidence of myocardial ischemia or central nervous system dysfunction present with labetalol treatment. Blood samples were obtained for determination of plasma renin activity, epinephrine, and norepinephrine in 10 patients who developed hypertension and received labetalol, and 10 patients who did not develop hypertension. In the patients developing hypertension, there was a significant elevation in epinephrine just before treatment, that decreased by 30 minutes after treatment. Norepinephrine levels became significantly elevated five minutes after labetalol treatment in the group with hypertension and remained elevated for 120 minutes. Concomitantly, there was a significantly lower plasma renin activity seen in this group.(ABSTRACT TRUNCATED AT 250 WORDS)
Asunto(s)
Endarterectomía Carotidea/efectos adversos , Hipertensión/tratamiento farmacológico , Labetalol/uso terapéutico , Antagonistas Adrenérgicos beta/uso terapéutico , Anciano , Presión Sanguínea/efectos de los fármacos , Bloqueadores de los Canales de Calcio/uso terapéutico , Clonidina/uso terapéutico , Efedrina/uso terapéutico , Epinefrina/sangre , Femenino , Frecuencia Cardíaca/efectos de los fármacos , Humanos , Hipertensión/sangre , Hipertensión/etiología , Hipotensión/prevención & control , Inyecciones Intravenosas , Masculino , Norepinefrina/sangre , Renina/sangre , Factores de TiempoRESUMEN
Pipecuronium bromide is a new steroidal non-depolarizing muscle relaxant currently under investigation. It is similar to pancuronium with respect to the duration of action, but lacking its cardiovascular side effects. We examined the dose-response relation of pipecuronium in 27 patients, ages 66-79 years, utilizing the incremental dose method under balanced anesthesia. The ED50, ED90 and ED95 were 22.42 (5.2) mcg/kg, 31.81 (6.9) mcg/kg and 35.12 (7.8) mcg/kg, respectively (log probit method). Our recovery data also demonstrate that residual neuromuscular blockade due to pipecuronium can easily be antagonized with neostigmine as long as spontaneous recovery of T1- at the time of reversal administration is greater than 13%. The authors conclude that under balanced anesthesia the cumulative dose-response of pipecuronium in the elderly patients is consistent with those previously described for younger population. Therefore, no dose adjustment appears necessary for the elderly. However, as with all medications, careful administration is appropriate.
Asunto(s)
Androstano-3,17-diol/farmacología , Androstanoles/farmacología , Contracción Muscular/efectos de los fármacos , Relajantes Musculares Centrales/farmacología , Relajación Muscular/efectos de los fármacos , Bloqueantes Neuromusculares/farmacología , Piperazinas/farmacología , Anciano , Androstano-3,17-diol/administración & dosificación , Androstano-3,17-diol/análogos & derivados , Androstano-3,17-diol/antagonistas & inhibidores , Anestesia , Relación Dosis-Respuesta a Droga , Femenino , Humanos , Masculino , Neostigmina/farmacología , Pipecuronio , Piperazinas/administración & dosificación , Piperazinas/antagonistas & inhibidores , Factores de TiempoRESUMEN
A comparison was made of the incidence of postoperative myalgia (POM) and fasciculations when atracurium (ATR) or d-Tubocurarine (DTC) was given prior to succinylcholine (SDC) for facilitation of tracheal intubation. The subjects were 44 ASA physical status I or II outpatient females undergoing laparoscopy. They were assigned to one of three groups: Group 1 received 0.025 mg/kg ATR; Group 2 received 0.05 mg/kg DTC, and Group 3 received saline (NS). Thiopental was administered one minute and 45 seconds after pretreatment. Three minutes after pretreatment, SDC 1.5 mg/kg was given, and fasciculations were recorded on a scale of 0-3. The patients were questioned one and three days postoperatively about POM and their responses recorded using a scale of 0-3. Fasciculations occurred in 79% of patients given saline, in 46% of those receiving ATR and in 12% of those given DTC. Eighty-five percent of ATR patients were free of POM on postoperative day one. The corresponding figures for DTC and NS were 59% and 43%, respectively. The difference between ATR and NS achieved statistical significance, leading to the conclusion that DTC is a better defasciculant than ATR. DTC was, however, not significantly better than NS in the prevention of POM. Findings suggest that ATR may be the drug of choice for the prevention of POM.
Asunto(s)
Atracurio/uso terapéutico , Enfermedades Musculares/inducido químicamente , Succinilcolina/efectos adversos , Adolescente , Adulto , Método Doble Ciego , Fasciculación/inducido químicamente , Femenino , Humanos , Intubación Intratraqueal , Persona de Mediana Edad , Tubocurarina/uso terapéuticoRESUMEN
Twenty ASA physical status Class III patients undergoing cadaver renal transplantation were studied. After 90 per cent T1 recovery, as determined by train-of-four measurement, from 1.0 mg.kg-1 succinylcholine to facilitate tracheal intubation, nine patients received atracurium 0.25 mg.kg-1 (Group I) and 11 patients received vecuronium 0.05 mg.kg-1 (Group II) intravenously. The following measurements were made: time to maximum block onset (first dose Max), injection to start of recovery (start REC1), injection to 25 per cent T1 twitch recovery (REC 251), injection to 75 per cent T1 (REC 75(1], injection to 90 per cent T1 (REC 90(1] and time from 25-75 per cent recovery T1 (REC 25-75(1]. Maximum blockade (Max block 1) was also measured. At 90 per cent T1 recovery, if time permitted, an identical dose of the appropriate relaxant was administered. Time from second dose to onset of maximum block (second dose Max) and 90 per cent recovery after second dose (REC 90(2] were then measured. At the conclusion of surgery, neuromuscular blockade was reversed with neostigmine 2.5 mg and glycopyrrolate 0.5 mg. One way ANOVA was performed to determine significance between the groups and a p less than 0.05 was considered significant. A paired t test was also performed between REC 90(1) and REC 90(2) for atracurium and vecuronium respectively. A p less than 0.05 was again considered significant. Measurement of first dose Max, start REC1, REC25(1), REC 75(1), REC 90(1), REC 25-75(1) and Max block 1 revealed no difference between the patients receiving an initial dose of atracurium and those receiving vecuronium.(ABSTRACT TRUNCATED AT 250 WORDS)
Asunto(s)
Atracurio/farmacología , Trasplante de Riñón , Unión Neuromuscular/efectos de los fármacos , Bromuro de Vecuronio/farmacología , Adulto , Humanos , Persona de Mediana Edad , Bromuro de Vecuronio/farmacocinéticaRESUMEN
Priming with vecuronium was evaluated in three groups of patients. Group 1 (n = 10) received tubocurarine 0.05 mg kg-1, group 2 (n = 19) received physiological saline and group 3 (n = 21) received vecuronium 0.012 mg kg-1. After 4 min maximum inspiratory pressure was measured. Anaesthesia was induced with thiopentone 6-8 mg kg-1 and controlled ventilation with nitrous oxide and oxygen via a face mask instituted. The ulnar nerve was stimulated at the wrist. At 5 min group 1 patients received suxamethonium 1.5 mg kg-1, group 2 received vecuronium 0.072 mg kg-1, and group 3 received vecuronium 0.060 mg kg-1. Intubation was accomplished at 6.5 min in all patients in group 1, 89% in group 2 and 90% in group 3. Patients in group 1 had no twitch response to stimulation at the time of intubation. Mean T4:T1 ratios at 6.5 min were 0.82 in group 2 and 0.61 in group 3 (P less than 0.05). Intubating conditions were excellent in all group 1 patients, and in 53% and 67% of groups 2 and 3, respectively. Two patients in group 3 did not tolerate the priming dose and many had subjective complaints. Four group 3 patients could not sustain head lift and five showed decreased inspiratory pressure. Priming did not improve intubating conditions when compared with a single bolus technique and was not well tolerated.
Asunto(s)
Intubación Intratraqueal , Bromuro de Vecuronio/administración & dosificación , Adulto , Evaluación de Medicamentos , Humanos , Succinilcolina , Factores de Tiempo , TubocurarinaRESUMEN
We compared the incidence of postoperative myalgia (POM) and fasciculations when atracurium (ATR) or d-tubocurarine (DTC) was given prior to succinylcholine (SDC) for tracheal intubation in 44 ASA class I or II outpatient females undergoing laparoscopy. The subjects were assigned to one of three groups: group 1 received 0.025 mg/kg ATR; group 2 received 0.05 mg/kg DTC; and group 3 received saline (NS), all in a double-blind manner. Thiopental was administered 1 min and 45 sec after pretreatment in doses adequate to allow control of ventilation. Three minutes after pretreatment, SDC 1.5 mg/kg was given, and fasciculations were recorded on a scale of 0-3. All patients were questioned 1 and 3 days postoperatively about POM, using a scale of 0-3. Fasciculations occurred in 79% of patients given saline, in 46% of those receiving ATR, and in 12% of those given DTC. Eighty-five percent of ATR patients were free of POM on postoperative day 1. The corresponding figures for DTC and NS were 59% and 43%, respectively. Only the difference between ATR and NS achieved statistical significance. On the third postoperative day, POM was rare and there were no significant differences among the groups. We conclude that DTC is a better defasciculant than ATR. DTC was, however, not significantly better than NS in the prevention of POM. The findings suggest that ATR may be the drug choice for the prevention of POM.
Asunto(s)
Atracurio , Enfermedades Musculares/prevención & control , Dolor Postoperatorio/prevención & control , Succinilcolina , Tubocurarina , Adolescente , Adulto , Ensayos Clínicos como Asunto , Método Doble Ciego , Fasciculación/prevención & control , Femenino , Humanos , Intubación Intratraqueal , Laparoscopía , Persona de Mediana Edad , Distribución Aleatoria , TiopentalAsunto(s)
Axila , Plexo Braquial , Mano/cirugía , Bloqueo Nervioso/métodos , Adulto , Anciano , Humanos , Persona de Mediana EdadRESUMEN
Priming with atracurium was evaluated by dividing 39 patients into 2 groups. All received 0.2 mg IV glycopyrrolate and fentanyl, 50 micrograms IV. Group 1 received saline, group 2 received 0.06 mg/kg atracurium and a stop watch was started. After 3.5 min the patients were asked to lift their heads and maximum negative inspiratory pressure (MIP) was measured. Anesthesia then commenced with thiopental and a twitch monitor was applied to the ulnar nerve. At 5 min group 1 received 0.36 mg/kg atracurium and group 2 was given 0.30 mg/kg atracurium. At 6.5 min intubation was accomplished in all but one patient in group 1 and all but one in group 2. Mean T4/T1 ratios at 90 sec were 0.73 in group 1 and 0.51 in group 2. This difference was statistically significant (P less than 0.001). Bucking on the endotracheal tube occurred in 72% of patients in group 1 and 62% of those in group 2 (not significant). Intubating conditions were "excellent" in 56% of those in group 1 and 75% in group 2 (not significant). "Good" conditions were seen in 33% of group 1 and 15% of group 2 patients (not significant). "Fair" conditions were noted in 6% of patients in group 1 and 5% of group 2 patients (not significant). The time to maximum twitch depression was 11.3 min and 11.5 min in groups 1 and 2 respectively (not significant). All patients in group 1 could sustain head lift whereas four patients in group 2 could not (not significant).(ABSTRACT TRUNCATED AT 250 WORDS)